Impact of the iWHELD digital person-centered care program on quality of life, agitation and psychotropic medications in people with dementia living in nursing homes during the COVID-19 pandemic: A randomized controlled trial
dc.contributor.author | McDermid, J | |
dc.contributor.author | Henley, W | |
dc.contributor.author | Corbett, A | |
dc.contributor.author | Williams, G | |
dc.contributor.author | Fossey, J | |
dc.contributor.author | Clare, L | |
dc.contributor.author | Fox, C | |
dc.contributor.author | Aarsland, D | |
dc.contributor.author | Khan, Z | |
dc.contributor.author | Soto, M | |
dc.contributor.author | Woodward-Carlton, B | |
dc.contributor.author | Cook, EM | |
dc.contributor.author | Cummings, J | |
dc.contributor.author | Sweetnam, A | |
dc.contributor.author | Chan, X | |
dc.contributor.author | Lawrence, M | |
dc.contributor.author | Ballard, C | |
dc.contributor.author | iWHELD study group | |
dc.date.accessioned | 2024-01-05T16:29:01Z | |
dc.date.issued | 2023-12-20 | |
dc.date.updated | 2024-01-05T14:55:19Z | |
dc.description.abstract | INTRODUCTION: iWHELD is a digital person-centered care program for people with dementia in nursing homes adapted for remote delivery during the COVID-19 pandemic. METHODS: A 16-week two-arm cluster-randomized controlled trial in 149 UK nursing homes compared iWHELD with treatment as usual (TAU). Primary outcome was the overall quality of life with secondary outcomes of agitation and psychotropic use. RESULTS: iWHELD conferred benefit to quality of life on the primary (F = 4.3, p = 0.04) and secondary measures of quality of life (F = 6.45, p = 0.01) and reduced psychotropic medication use (χ2 = 4.08, p = 0.04) with no worsening of agitation. Benefit was seen in participants who contracted COVID-19, those with agitation at baseline, and those taking psychotropic medications. DISCUSSION: iWHELD confers benefits to quality of life and key measures of well-being, can be delivered during the challenging conditions of a pandemic, and should be considered for use alongside any emerging pharmacological treatment for neuropsychiatric symptoms. HIGHLIGHTS: iWHELD is the only remote, digital delivery nursing home training programme for dementia care iWHELD improved quality of life in people with dementia and reduced antipsychotic use without worsening of agitation Residents who contracted Covid-19 during the study also experienced benefits from iWHELD iWHELD offers a valuable, pandemic-safe tool for improving dementia care. | en_GB |
dc.description.sponsorship | Medical Research Council (MRC) | en_GB |
dc.description.sponsorship | National Institute for Health and Care Research (NIHR) | en_GB |
dc.format.medium | Print-Electronic | |
dc.identifier.citation | Published online 20 December 2023 | en_GB |
dc.identifier.doi | https://doi.org/10.1002/alz.13582 | |
dc.identifier.uri | http://hdl.handle.net/10871/134916 | |
dc.identifier | ORCID: 0000-0003-2015-0316 (Corbett, Anne) | |
dc.identifier | ScopusID: 35572940700 (Corbett, Anne) | |
dc.identifier | ResearcherID: B-3223-2014 (Corbett, Anne) | |
dc.identifier | ORCID: 0000-0001-9480-5704 (Fox, Chris) | |
dc.identifier | ORCID: 0000-0003-0022-5632 (Ballard, Clive) | |
dc.identifier | ScopusID: 35351371500 | 57200261353 | 57203270570 (Ballard, Clive) | |
dc.language.iso | en | en_GB |
dc.publisher | Wiley / Alzheimer's Association | en_GB |
dc.relation.url | https://www.ncbi.nlm.nih.gov/pubmed/38116916 | en_GB |
dc.rights | © 2023 The Authors. Alzheimer’s & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer’s Association. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. | en_GB |
dc.subject | COVID-19 | en_GB |
dc.subject | agitation | en_GB |
dc.subject | dementia | en_GB |
dc.subject | digital | en_GB |
dc.subject | iWHELD | en_GB |
dc.subject | nursing home | en_GB |
dc.subject | person-centered care | en_GB |
dc.subject | psychotropic | en_GB |
dc.subject | quality of life | en_GB |
dc.title | Impact of the iWHELD digital person-centered care program on quality of life, agitation and psychotropic medications in people with dementia living in nursing homes during the COVID-19 pandemic: A randomized controlled trial | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2024-01-05T16:29:01Z | |
dc.identifier.issn | 1552-5260 | |
exeter.place-of-publication | United States | |
dc.description | This is the final version. Available on open access from Wiley via the DOI in this record | en_GB |
dc.identifier.eissn | 1552-5279 | |
dc.identifier.journal | Alzheimer's & Dementia: The Journal of the Alzheimer's Association | en_GB |
dc.relation.ispartof | Alzheimers Dement | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_GB |
dcterms.dateAccepted | 2023-10-29 | |
rioxxterms.version | VoR | en_GB |
rioxxterms.licenseref.startdate | 2023-12-20 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2024-01-05T16:27:28Z | |
refterms.versionFCD | VoR | |
refterms.dateFOA | 2024-01-05T16:29:10Z | |
refterms.panel | A | en_GB |
refterms.dateFirstOnline | 2023-12-20 |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © 2023 The Authors. Alzheimer’s & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer’s Association. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided
the original work is properly cited.